Phase II, Single-Arm Trial of Induction and Concurrent Vismodegib With Curative-Intent Radiation Therapy for Locally Advanced, Unresectable Basal Cell Carcinoma Patients with SCLC and progression on ...
Breast cancer is a complex disease and there are several molecular alterations associated with its pathogenesis. Although considerable efforts have been made for the development of effective therapy ...
Understanding these microscopic messengers could change the fight against metastasis. Preventing cancer from spreading ...
The phase III RESILIENT trial compared second-line liposomal irinotecan with topotecan in patients with small cell lung cancer (SCLC). Patients with SCLC and progression on or after first-line ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
The Nature Index 2025 Research Leaders — previously known as Annual Tables — reveal the leading institutions and countries/territories in the natural and health sciences, according to their output in ...
CMV-SPORT-β-gal Haloperidol Sigma receptors Haloperidol-conjugated targeted lipoplex showed tenfold higher reporter gene expression in MCF-7 cells in comparison to control lipoplex [123] p53 Estradiol ...
Patients with SCLC and progression on or after first-line platinum-based chemotherapy were randomly assigned (1:1) to intravenous (IV) liposomal irinotecan (70 mg/m 2 every 2 weeks in a 6-week cycle) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results